Abstract
Original language | English |
---|---|
Journal | PLoS One |
Volume | 7 |
Issue number | 9 |
DOIs | |
Publication status | Published - 2012 |
Externally published | Yes |
Keywords
- galactosamine
- gamma interferon
- glutathione
- heme oxygenase 1
- inducible nitric oxide synthase
- interleukin 15
- interleukin 1beta
- paracetamol
- recombinant interleukin 15
- tumor necrosis factor alpha
- animal cell
- animal experiment
- animal model
- animal tissue
- article
- cell infiltration
- cell transport
- controlled study
- cytokine production
- disease predisposition
- drug metabolism
- knockout mouse
- Kupffer cell
- liver cell
- male
- monocyte
- mouse
- neutrophil
- nonhuman
- protein blood level
- protein deficiency
- survival
- toxic hepatitis
- wild type
- Acetaminophen
- Animals
- Antibodies, Neutralizing
- Disease Susceptibility
- Dose-Response Relationship, Drug
- Drug-Induced Liver Injury
- Enzyme Induction
- Gene Knockout Techniques
- Heme Oxygenase-1
- Hepatitis
- Interleukin-15
- Kupffer Cells
- Liver
- Male
- Mice
- Mice, Inbred C57BL
- Nitric Oxide Synthase Type II
- Organ Specificity
- Recombinant Proteins
- Transcription, Genetic
- Animalia
- Mus
Access to Document
Fingerprint
Dive into the research topics of 'Deficiency of Interleukin-15 Enhances Susceptibility to Acetaminophen-Induced Liver Injury in Mice'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: PLoS One, Vol. 7, No. 9, 2012.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Deficiency of Interleukin-15 Enhances Susceptibility to Acetaminophen-Induced Liver Injury in Mice
AU - Hou, Hsein-San
AU - Liao, Ching-Len
AU - Sytwu, Huey-Kang
AU - Liao, Nan-Shih
AU - Huang, Tien-Yu
AU - Hsieh, Tsai-Yuan
AU - Chu, Heng-Cheng
N1 - 被引用次數:6 Export Date: 22 March 2016 通訊地址: Chu, H.-C.; Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan; 電子郵件: [email protected] 化學物質/CAS: galactosamine, 7535-00-4; gamma interferon, 82115-62-6; glutathione, 70-18-8; inducible nitric oxide synthase, 501433-35-8; paracetamol, 103-90-2; Acetaminophen, 103-90-2; Antibodies, Neutralizing; Heme Oxygenase-1, 1.14.99.3; Interleukin-15; Nitric Oxide Synthase Type II, 1.14.13.39; Recombinant Proteins 參考文獻: Dahlin, D.C., Miwa, G.T., Lu, A.Y., Nelson, S.D., N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen (1984) Proc Natl Acad Sci U S A, 81, pp. 1327-1331; Mitchell, J.R., Jollow, D.J., Potter, W.Z., Gillette, J.R., Brodie, B.B., Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione (1973) J Pharmacol Exp Ther, 187, pp. 211-217; Jaeschke, H., Glutathione disulfide formation and oxidant stress during acetaminophen-induced hepatotoxicity in mice in vivo: the protective effect of allopurinol (1990) J Pharmacol Exp Ther, 255, pp. 935-941; Kon, K., Kim, J.S., Jaeschke, H., Lemasters, J.J., Mitochondrial permeability transition in acetaminophen-induced necrosis and apoptosis of cultured mouse hepatocytes (2004) Hepatology, 40, pp. 1170-1179; Chiu, H., Brittingham, J.A., Laskin, D.L., Differential induction of heme oxygenase-1 in macrophages and hepatocytes during acetaminophen-induced hepatotoxicity in the rat: effects of hemin and biliverdin (2002) Toxicol Appl Pharmacol, 181, pp. 106-115; Kaplowitz, N., Idiosyncratic drug hepatotoxicity (2005) Nat Rev Drug Discov, 4, pp. 489-499; Liu, Z.X., Govindarajan, S., Kaplowitz, N., Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity (2004) Gastroenterology, 127, pp. 1760-1774; Liu, Z.X., Han, D., Gunawan, B., Kaplowitz, N., Neutrophil depletion protects against murine acetaminophen hepatotoxicity (2006) Hepatology, 43, pp. 1220-1230; Connolly, M.K., Ayo, D., Malhotra, A., Hackman, M., Bedrosian, A.S., Dendritic cell depletion exacerbates acetaminophen hepatotoxicity (2011) Hepatology, 54, pp. 959-968; Michael, S.L., Pumford, N.R., Mayeux, P.R., Niesman, M.R., Hinson, J.A., Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species (1999) Hepatology, 30, pp. 186-195; Ju, C., Reilly, T.P., Bourdi, M., Radonovich, M.F., Brady, J.N., Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice (2002) Chem Res Toxicol, 15, pp. 1504-1513; Masson, M.J., Carpenter, L.D., Graf, M.L., Pohl, L.R., Pathogenic role of natural killer T and natural killer cells in acetaminophen-induced liver injury in mice is dependent on the presence of dimethyl sulfoxide (2008) Hepatology, 48, pp. 889-897; Cover, C., Liu, J., Farhood, A., Malle, E., Waalkes, M.P., Pathophysiological role of the acute inflammatory response during acetaminophen hepatotoxicity (2006) Toxicol Appl Pharmacol, 216, pp. 98-107; Bourdi, M., Masubuchi, Y., Reilly, T.P., Amouzadeh, H.R., Martin, J.L., Protection against acetaminophen-induced liver injury and lethality by interleukin 10: role of inducible nitric oxide synthase (2002) Hepatology, 35, pp. 289-298; Masubuchi, Y., Bourdi, M., Reilly, T.P., Graf, M.L., George, J.W., Role of interleukin-6 in hepatic heat shock protein expression and protection against acetaminophen-induced liver disease (2003) Biochem Biophys Res Commun, 304, pp. 207-212; Yee, S.B., Bourdi, M., Masson, M.J., Pohl, L.R., Hepatoprotective role of endogenous interleukin-13 in a murine model of acetaminophen-induced liver disease (2007) Chem Res Toxicol, 20, pp. 734-744; Blazka, M.E., Wilmer, J.L., Holladay, S.D., Wilson, R.E., Luster, M.I., Role of proinflammatory cytokines in acetaminophen hepatotoxicity (1995) Toxicol Appl Pharmacol, 133, pp. 43-52; Ishida, Y., Kondo, T., Ohshima, T., Fujiwara, H., Iwakura, Y., A pivotal involvement of IFN-gamma in the pathogenesis of acetaminophen-induced acute liver injury (2002) FASEB J, 16, pp. 1227-1236; Imaeda, A.B., Watanabe, A., Sohail, M.A., Mahmood, S., Mohamadnejad, M., Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome (2009) J Clin Invest, 119, pp. 305-314; Budagian, V., Bulanova, E., Paus, R., Bulfone-Paus, S., IL-15/IL-15 receptor biology: a guided tour through an expanding universe (2006) Cytokine Growth Factor Rev, 17, pp. 259-280; Ma, A., Koka, R., Burkett, P., Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis (2006) Annu Rev Immunol, 24, pp. 657-679; Ohteki, T., Suzue, K., Maki, C., Ota, T., Koyasu, S., Critical role of IL-15-IL-15R for antigen-presenting cell functions in the innate immune response (2001) Nat Immunol, 2, pp. 1138-1143; Bouchard, A., Ratthe, C., Girard, D., Interleukin-15 delays human neutrophil apoptosis by intracellular events and not via extracellular factors: role of Mcl-1 and decreased activity of caspase-3 and caspase-8 (2004) J Leukoc Biol, 75, pp. 893-900; Alleva, D.G., Kaser, S.B., Monroy, M.A., Fenton, M.J., Beller, D.I., IL-15 functions as a potent autocrine regulator of macrophage proinflammatory cytokine production: evidence for differential receptor subunit utilization associated with stimulation or inhibition (1997) J Immunol, 159, pp. 2941-2951; Li, B., Sun, R., Wei, H., Gao, B., Tian, Z., Interleukin-15 prevents concanavalin A-induced liver injury in mice via NKT cell-dependent mechanism (2006) Hepatology, 43, pp. 1211-1219; Bulfone-Paus, S., Ungureanu, D., Pohl, T., Lindner, G., Paus, R., Interleukin-15 protects from lethal apoptosis in vivo (1997) Nat Med, 3, pp. 1124-1128; Ohteki, T., Tada, H., Ishida, K., Sato, T., Maki, C., Essential roles of DC-derived IL-15 as a mediator of inflammatory responses in vivo (2006) J Exp Med, 203, pp. 2329-2338; Kuwajima, S., Sato, T., Ishida, K., Tada, H., Tezuka, H., Interleukin 15-dependent crosstalk between conventional and plasmacytoid dendritic cells is essential for CpG-induced immune activation (2006) Nat Immunol, 7, pp. 740-746; Suzuki, A., McCall, S., Choi, S.S., Sicklick, J.K., Huang, J., Interleukin-15 increases hepatic regenerative activity (2006) J Hepatol, 45, pp. 410-418; Grabstein, K.H., Eisenman, J., Shanebeck, K., Rauch, C., Srinivasan, S., Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor (1994) Science, 264, pp. 965-968; Misra, I., Griffith, O.W., Expression and purification of human gamma-glutamylcysteine synthetase (1998) Protein Expr Purif, 13, pp. 268-276; Ferret, P.J., Hammoud, R., Tulliez, M., Tran, A., Trebeden, H., Detoxification of reactive oxygen species by a nonpeptidyl mimic of superoxide dismutase cures acetaminophen-induced acute liver failure in the mouse (2001) Hepatology, 33, pp. 1173-1180; Aleksunes, L.M., Manautou, J.E., Emerging role of Nrf2 in protecting against hepatic and gastrointestinal disease (2007) Toxicol Pathol, 35, pp. 459-473; Holt, M.P., Cheng, L., Ju, C., Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury (2008) J Leukoc Biol, 84, pp. 1410-1421; Hinson, J.A., Bucci, T.J., Irwin, L.K., Michael, S.L., Mayeux, P.R., Effect of inhibitors of nitric oxide synthase on acetaminophen-induced hepatotoxicity in mice (2002) Nitric Oxide, 6, pp. 160-167; Sumioka, I., Matsura, T., Kai, M., Yamada, K., Potential roles of hepatic heat shock protein 25 and 70i in protection of mice against acetaminophen-induced liver injury (2004) Life Sci, 74, pp. 2551-2561; Nussler, A.K., Di Silvio, M., Liu, Z.Z., Geller, D.A., Freeswick, P., Further characterization and comparison of inducible nitric oxide synthase in mouse, rat, and human hepatocytes (1995) Hepatology, 21, pp. 1552-1560; Maley, F., Tarentino, A.L., McGarrahan, J.F., Delgiacco, R., The metabolism of d-galactosamine and N-acetyl-d-galactosamine in rat liver (1968) Biochem J, 107, pp. 637-644; Jaeschke, H., Williams, C.D., Ramachandran, A., Bajt, M.L., Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity (2012) Liver Int, 32, pp. 8-20; Sakamoto, N., Sun, Z., Brengman, M.L., Maemura, K., Ozaki, M., Hepatic reticuloendothelial system dysfunction after ischemia-reperfusion: role of P-selectin-mediated neutrophil accumulation (2003) Liver Transpl, 9, pp. 940-948; Possamai, L.A., Antoniades, C.G., Anstee, Q.M., Quaglia, A., Vergani, D., Role of monocytes and macrophages in experimental and human acute liver failure (2010) World J Gastroenterol, 16, pp. 1811-1819; Harstad, E.B., Klaassen, C.D., Gadolinium chloride pretreatment prevents cadmium chloride-induced liver damage in both wild-type and MT-null mice (2002) Toxicol Appl Pharmacol, 180, pp. 178-185; Bourdi, M., Davies, J.S., Pohl, L.R., Mispairing C57BL/6 substrains of genetically engineered mice and wild-type controls can lead to confounding results as it did in studies of JNK2 in acetaminophen and concanavalin A liver injury (2011) Chem Res Toxicol, 24, pp. 794-796; Hoetzel, A., Vagts, D.A., Loop, T., Humar, M., Bauer, M., Effect of nitric oxide on shock-induced hepatic heme oxygenase-1 expression in the rat (2001) Hepatology, 33, pp. 925-937; Lehmann, V., Freudenberg, M.A., Galanos, C., Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice (1987) J Exp Med, 165, pp. 657-663; Knight, T.R., Jaeschke, H., Acetaminophen-induced inhibition of Fas receptor-mediated liver cell apoptosis: mitochondrial dysfunction versus glutathione depletion (2002) Toxicol Appl Pharmacol, 181, pp. 133-141; Le Moine, O., Louis, H., Demols, A., Desalle, F., Demoor, F., Cold liver ischemia-reperfusion injury critically depends on liver T cells and is improved by donor pretreatment with interleukin 10 in mice (2000) Hepatology, 31, pp. 1266-1274; Ruckert, R., Brandt, K., Ernst, M., Marienfeld, K., Csernok, E., Interleukin-15 stimulates macrophages to activate CD4+ T cells: a role in the pathogenesis of rheumatoid arthritis? (2009) Immunology, 126, pp. 63-73; Nishimura, H., Washizu, J., Nakamura, N., Enomoto, A., Yoshikai, Y., Translational efficiency is up-regulated by alternative exon in murine IL-15 mRNA (1998) J Immunol, 160, pp. 936-942; Meazza, R., Verdiani, S., Biassoni, R., Coppolecchia, M., Gaggero, A., Identification of a novel interleukin-15 (IL-15) transcript isoform generated by alternative splicing in human small cell lung cancer cell lines (1996) Oncogene, 12, pp. 2187-2192; Onu, A., Pohl, T., Krause, H., Bulfone-Paus, S., Regulation of IL-15 secretion via the leader peptide of two IL-15 isoforms (1997) J Immunol, 158, pp. 255-262; Tagaya, Y., Kurys, G., Thies, T.A., Losi, J.M., Azimi, N., Generation of secretable and nonsecretable interleukin 15 isoforms through alternate usage of signal peptides (1997) Proc Natl Acad Sci U S A, 94, pp. 14444-14449; Musikacharoen, T., Oguma, A., Yoshikai, Y., Chiba, N., Masuda, A., Interleukin-15 induces IL-12 receptor beta1 gene expression through PU.1 and IRF 3 by targeting chromatin remodeling (2005) Blood, 105, pp. 711-720; Mirghomizadeh, F., Bullwinkel, J., Orinska, Z., Janssen, O., Petersen, A., Transcriptional regulation of mouse mast cell protease-2 by interleukin-15 (2009) J Biol Chem, 284, pp. 32635-32641; Yoshihara, K., Yajima, T., Kubo, C., Yoshikai, Y., Role of interleukin 15 in colitis induced by dextran sulphate sodium in mice (2006) Gut, 55, pp. 334-341; Nakamura, R., Maeda, N., Shibata, K., Yamada, H., Kase, T., Interleukin-15 is critical in the pathogenesis of influenza a virus-induced acute lung injury (2010) J Virol, 84, pp. 5574-5582; Shinozaki, M., Hirahashi, J., Lebedeva, T., Liew, F.Y., Salant, D.J., IL-15, a survival factor for kidney epithelial cells, counteracts apoptosis and inflammation during nephritis (2002) J Clin Invest, 109, pp. 951-960; Gomez-Nicola, D., Spagnolo, A., Guaza, C., Nieto-Sampedro, M., Aggravated experimental autoimmune encephalomyelitis in IL-15 knockout mice (2010) Exp Neurol, 222, pp. 235-242; Conti, F., Frappier, J., Dharancy, S., Chereau, C., Houssin, D., Interleukin-15 production during liver allograft rejection in humans (2003) Transplantation, 76, pp. 210-216; Kakumu, S., Okumura, A., Ishikawa, T., Yano, M., Enomoto, A., Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease (1997) Clin Exp Immunol, 109, pp. 458-463
PY - 2012
Y1 - 2012
N2 - Hepatocytes have a direct necrotic role in acetaminophen (APAP)-induced liver injury (AILI), prolonged secondary inflammatory response through innate immune cells and cytokines also significantly contributes to APAP hepatotoxicity. Interleukin 15 (IL-15), a multifunction cytokine, regulates the adaptive immune system and influences development and function of innate immune cells. To better understand the role of IL-15 in liver injury, we treated wild-type (WT) and IL-15-knockout (Il15-/-) mice with a hepatotoxic dose of APAP to induce AILI and evaluated animal survival, liver damage, APAP metabolism in livers and the inflammatory response. Production of pro-inflammatory cytokines/chemokines was greater in Il15-/- than WT mice. Subanalysis of hepatic infiltrated monocytes revealed greater neutrophil influx, along with greater hepatic induction of inducible nitric oxide synthase (iNOS), in Il15-/- than WT mice. In addition, the level of hepatic hemeoxygenase 1 (HO-1) was partially suppressed in Il15-/- mice, but not in WT mice. Interestingly, elimination of Kupffer cells and neutrophils did not alter the vulnerability to excess APAP in Il15-/- mice. However, injection of galactosamine, a hepatic transcription inhibitor, significantly reduced the increased APAP sensitivity in Il15-/- mice but had minor effect on WT mice. We demonstrated that deficiency of IL-15 increased mouse susceptibility to AILI. Moreover, Kupffer cell might affect APAP hepatotoxicity through IL-15. © 2012 Hou et al.
AB - Hepatocytes have a direct necrotic role in acetaminophen (APAP)-induced liver injury (AILI), prolonged secondary inflammatory response through innate immune cells and cytokines also significantly contributes to APAP hepatotoxicity. Interleukin 15 (IL-15), a multifunction cytokine, regulates the adaptive immune system and influences development and function of innate immune cells. To better understand the role of IL-15 in liver injury, we treated wild-type (WT) and IL-15-knockout (Il15-/-) mice with a hepatotoxic dose of APAP to induce AILI and evaluated animal survival, liver damage, APAP metabolism in livers and the inflammatory response. Production of pro-inflammatory cytokines/chemokines was greater in Il15-/- than WT mice. Subanalysis of hepatic infiltrated monocytes revealed greater neutrophil influx, along with greater hepatic induction of inducible nitric oxide synthase (iNOS), in Il15-/- than WT mice. In addition, the level of hepatic hemeoxygenase 1 (HO-1) was partially suppressed in Il15-/- mice, but not in WT mice. Interestingly, elimination of Kupffer cells and neutrophils did not alter the vulnerability to excess APAP in Il15-/- mice. However, injection of galactosamine, a hepatic transcription inhibitor, significantly reduced the increased APAP sensitivity in Il15-/- mice but had minor effect on WT mice. We demonstrated that deficiency of IL-15 increased mouse susceptibility to AILI. Moreover, Kupffer cell might affect APAP hepatotoxicity through IL-15. © 2012 Hou et al.
KW - galactosamine
KW - gamma interferon
KW - glutathione
KW - heme oxygenase 1
KW - inducible nitric oxide synthase
KW - interleukin 15
KW - interleukin 1beta
KW - paracetamol
KW - recombinant interleukin 15
KW - tumor necrosis factor alpha
KW - animal cell
KW - animal experiment
KW - animal model
KW - animal tissue
KW - article
KW - cell infiltration
KW - cell transport
KW - controlled study
KW - cytokine production
KW - disease predisposition
KW - drug metabolism
KW - knockout mouse
KW - Kupffer cell
KW - liver cell
KW - male
KW - monocyte
KW - mouse
KW - neutrophil
KW - nonhuman
KW - protein blood level
KW - protein deficiency
KW - survival
KW - toxic hepatitis
KW - wild type
KW - Acetaminophen
KW - Animals
KW - Antibodies, Neutralizing
KW - Disease Susceptibility
KW - Dose-Response Relationship, Drug
KW - Drug-Induced Liver Injury
KW - Enzyme Induction
KW - Gene Knockout Techniques
KW - Heme Oxygenase-1
KW - Hepatitis
KW - Interleukin-15
KW - Kupffer Cells
KW - Liver
KW - Male
KW - Mice
KW - Mice, Inbred C57BL
KW - Nitric Oxide Synthase Type II
KW - Organ Specificity
KW - Recombinant Proteins
KW - Transcription, Genetic
KW - Animalia
KW - Mus
U2 - 10.1371/journal.pone.0044880
DO - 10.1371/journal.pone.0044880
M3 - Article
SN - 1932-6203
VL - 7
JO - PLoS One
JF - PLoS One
IS - 9
ER -